Knowledge Ecology International
Attending and mending the knowledge ecosystem
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate
Homeยปevrysdi

evrysdi

The cost of trials used to support the initial FDA approval of risdiplam (Evrysdi)

Posted on April 23, 2025 by James Love

Cost of initial risdiplam trials The cost of trials used to support the initial FDA approval of risdiplam (Evrysdi) KEI Research Note 2025:2 James Packard Love April 23, 2025

Access to Medicine, Economics, Orphan Drugs, Research and Development evrysdi, risdiplam, Roche

Categories

  • About
  • Access to Knowledge
  • Access to Medicine
  • AI
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Site Articles
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
© 2025 Knowledge Ecology International. All rights reserved.
Hiero by aThemes